IL17A and chronic obstructive pulmonary disease: Others have reported IL-17-immunoreactive epithelial cells in the lower airways of cystic fibrosis or COPD patients [30], [64], in salivary epithelial cells in Sjögren syndrome [65] and tubular epithelial cells in renal transplants of recipients with graft rejection [66] by using IHC.